Clinical Trials Directory

Trials / Completed

CompletedNCT02551406

Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Centre d'Investigation Clinique et Technologique 805 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Different tools may be used to monitor the efficacy of home mechanical ventilation. Investigators aimed to compare the prognostic value of the different data obtained by capno-oxymetry in a mechanical ventilated neuromuscular disease's population.

Detailed description

Home mechanical ventilation (HMV) is used to treat hypoventilation, and its efficacy is mostly assessed by daytime blood gases and nocturnal oxymetry (SpO2). Transcutaneous CO2 measure (TcCO2) has shown higher sensitivity than SpO2 to detect hypoventilation in neuromuscular diseases (NMD) patients. No data exist on the prognostic value of these techniques to monitor mechanical ventilated NMD patients. Basing on retrospective data review, investigators aimed to compare the prognostic value of the data obtained using different tools to assess residual hypoventilation in the cohort of ventilated NMD patients followed at our reference center.

Conditions

Interventions

TypeNameDescription
DEVICECapno-oxymetry monitoringMonitoring of home mechanical ventilation by capno-oximetry

Timeline

Start date
2015-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-09-16
Last updated
2016-02-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02551406. Inclusion in this directory is not an endorsement.